Names | |
---|---|
Preferred IUPAC name
2-Aminoethyl dihydrogen phosphate | |
Other names
Phosphoethanolamine; PHOS
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.012.717 |
MeSH | phosphorylethanolamine |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C2H8NO4P | |
Molar mass | 141.063 g·mol−1 |
Appearance | White powder |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Phosphorylethanolamine or phosphoethanolamine is an ethanolamine derivative that is used to construct two different categories of phospholipids. One category termed a glycerophospholipid and the other a sphingomyelin, or more specifically within the sphingomyelin class, a sphingophospholipid. Phosphorylethanolamine is a polyprotic acid with two pKa values at 5.61 and 10.39.[1]
Phosphorylethanolamine has been falsely promoted as a cancer treatment.[2]
ee
was invoked but never defined (see the help page).